Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis C. Rodriguez-Torres M, Jeffers LJ, Sheikh MY, Rossaro L, Ankoma-Sey V, Hamzeh FM, Martin P, Latino Study Group (2009) N Engl J Med 360: 257-67 Pitavastatin enhances antiviral efficacy of standard pegylated interferon plus ribavirin in patients with chronic hepatitis C: a prospective randomized pilot study. Shimada M, Yoshida S, Masuzaki R, Schuppan D (2012) J Hepatol 56: 299-300 Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada. Knowles SR, Phillips EJ, Dresser L, Matukas L (2003) Clin Infect Dis 37: 1139-42 Ribavirin in the treatment of SARS: A new trick for an old drug? Koren G, King S, Knowles S, Phillips E (2003) CMAJ 168: 1289-92 Addition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naïve to HCV therapy: results of the ACTG A5269 trial. Amorosa VK, Luetkemeyer A, Kang M, Johnson VA, Umbleja T, Haas DW, Yesmin S, Bardin MC, Chung RT, Alston-Smith B, Tebas P, Peters MG (2013) HIV Clin Trials 14: 274-83
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.